🔥🐔 BizChicken 🐔🔥
Companies Similar to Scholar Rock Holding Corporation
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Alector, Inc.
AL001, AL101, AL002, AL003, AL044
Alector, Inc. is a clinical stage biopharmaceutical company focused on developing therapies for neurodegeneration diseases. The company has several products in various stages of clinical trials aimed at treating conditions such as Alzheimer's, Parkinson's, and frontotemporal dementia.
About | Vision/Values | History | Leadership | Contact | Culture | Vision/Values | History | About | About | About | About | Careers | About | About
Symbol: ALEC
Recent Price: $1.72
Industry: Biotechnology
CEO: Dr. Arnon Rosenthal Ph.D.
Sector: Healthcare
Employees: 245
Address: 131 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 415 231 5660
Leadership
- Arnon Rosenthal, Ph.D., Co-Founder, Chief Executive Officer, and Director
- Sara Kenkare-Mitra, Ph.D., President and Head of Research and Development
- Marc Grasso, M.D., Chief Financial Officer
- Gary Romano, M.D., Ph.D., Chief Medical Officer
- Danielle Pasqualone, Ph.D., J.D., General Counsel
- Clare Hunt, M.B.A., Chief People Officer
- Kristina Cutter, M.P.H., Chief Regulatory, Pharmacovigilance, and Quality Assurance Officer
- Virginia DeJesus-Rueff, M.B.A., Chief of Staff and Head of Strategy
- Norah Conway, Senior Vice President, Portfolio and Program Management
- Neil Berkley, M.S., M.B.A., Chief Business Officer
- Louis J. Lavigne Jr., M.B.A., Chairperson of the Board
- Elizabeth Garofalo, M.D., Board Member
- Paula Hammond, Ph.D., Board Member
- Richard H. Scheller, Ph.D., Board Member
- David Wehner, Board Member
- Kristine Yaffe, M.D., Board Member
- Errol De Souza, Ph.D., Board Member
- Mark Altmeyer, M.B.A., Board Member
Last updated: 2024-12-31
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
Fulcrum Therapeutics, Inc.
losmapimod and FTX-6058
Fulcrum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing products to improve the lives of patients with genetically defined diseases in areas of high unmet medical need in the United States.
Symbol: FULC
Recent Price: $4.68
Industry: Biotechnology
CEO: Mr. Alexander C. Sapir
Sector: Healthcare
Employees: 76
Address: 26 Landsdowne Street, Cambridge, MA 02139
Phone: 617 651 8851
Last updated: 2024-12-31
Supernus Pharmaceuticals, Inc.
Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC
Supernus Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system diseases, including epilepsy, migraine, ADHD, and Parkinson's Disease.
Symbol: SUPN
Recent Price: $36.91
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Jack A. Khattar M.B.A.
Sector: Healthcare
Employees: 652
Address: 9715 Key West Avenue, Rockville, MD 20850
Phone: 301 838 2500
Last updated: 2024-12-31
Scholar Rock Holding Corporation
Apitegromab
Scholar Rock Holding Corporation is a biopharmaceutical company focused on developing medicines for serious diseases where protein growth factor signaling plays a critical role. The company advances Apitegromab, targeting spinal muscular atrophy, and SRK-181 for cancer treatments, alongside a pipeline addressing neuromuscular disorders, cancer, and fibrosis.
About | About | About | News | Events | ESG | About | About | About | Careers | About | About | Leadership | Directors | About | Contact | Contact | Careers
Symbol: SRRK
Recent Price: $42.91
Industry: Biotechnology
CEO: Dr. Jay Thomas Backstrom M.D., M.P.H.
Sector: Healthcare
Employees: 150
Address: 301 Binney Street, Cambridge, MA 02142
Phone: 857 259 3860
Leadership
- David Hallal, Chairman of the Scholar Rock Board and Chief Executive Officer of ElevateBio
- Srini Akkaraju, MD, PhD, Founder & Managing Partner, Samsara BioCapital
- Jay Backstrom, M.D., MPH, President & CEO
- Richard Brudnick, Chief Business Officer, Prime Medicine
- Kristina Burow, Managing Director, ARCH Venture Partners
- Jeffrey Flier, MD, Higginson Professor of Physiology and Medicine and Harvard University Distinguished Service Professor; Former Dean of Harvard Medical School
- Michael Gilman, PhD, CEO, Arrakis Therapeutics
- Katie Peng, Chief Commercial Officer, Denali Therapeutics
- Joshua Reed, Chief Financial Officer of Omega Therapeutics
- Akshay Vaishnaw, MD, PhD, Chief Innovation Officer, Alnylam Pharmaceuticals
Last updated: 2024-12-31
Apogee Therapeutics, Inc.
APG777, APG808, APG990, APG222
Apogee Therapeutics, Inc. is a biotechnology company developing biologics for the treatment of atopic dermatitis, COPD, and related inflammatory and immunology conditions. Founded in 2022 and based in Waltham, Massachusetts.
Symbol: APGE
Recent Price: $44.64
Industry: Biotechnology
CEO: Dr. Michael Thomas Henderson M.D.
Sector: Healthcare
Employees: 91
Address: 221 Crescent Street, Waltham, MA 02453
Phone: 650-394-5230
Last updated: 2024-12-31
Apollomics, Inc.
APL-101 (Vebreltinib), APL-102, APL-122
Apollomics, Inc. is a biotechnology company that discovers and develops oncology therapies to address unmet medical needs, focusing on treatments for non-small cell lung cancer, liver cancer, breast cancer, esophageal cancer, and brain tumors.
Symbol: APLM
Recent Price: $10.13
Industry: Biotechnology
CEO: Dr. Guo-Liang Yu Ph.D.
Sector: Healthcare
Employees: 45
Address: 989 East Hillsdale Blvd, Foster City, CA 94404
Phone: 650 209 4055
Last updated: 2024-12-31
Apellis Pharmaceuticals, Inc.
pegcetacoplan
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapeutic compounds targeting the complement system for autoimmune and inflammatory diseases.
About | Leadership | Directors | About | About | Contact | Contact | Contact | Culture | Benefits | Careers | Careers | About | About
Symbol: APLS
Recent Price: $31.90
Industry: Biotechnology
CEO: Dr. Cedric Francois M.D., Ph.D.
Sector: Healthcare
Employees: 702
Address: 100 Fifth Avenue, Waltham, MA 02451
Phone: 617 977 5700
Leadership
- Cedric Francois, MD, PhD, Co-Founder & Chief Executive Officer/President
- Caroline Baumal, MD, Chief Medical Officer
- Mark DeLong, Chief Business & Strategy Officer
- Pascal Deschatelets, PhD, Co-Founder & Chief Scientific Officer
- Jeffrey Eisele, PhD, Chief Development Officer
- Karen Lewis, Chief People Officer
- Nur Nicholson, Chief Technical Operations Officer
- Timothy Sullivan, Chief Financial Officer
- Adam Townsend, Chief Operating Officer
- David Watson, JD, General Counsel
- Apellis Pharmaceuticals,
- Gerald Chan, Chairman
- Sinclair Dunlop, Director
- Stephanie Monaghan O’Brien, Director
- Paul Fonteyne, Director
- Cedric Francois, Co-Founder & Chief Executive Officer/President
- Alec Machiels, Co-Founder
Last updated: 2024-12-31
bluebird bio, Inc.
betibeglogene autotemcel, lovotibeglogene autotemcel, elivaldogene autotemcel
bluebird bio, Inc. is a biotechnology company that researches, develops, and commercializes transformative gene therapies for severe genetic diseases, including treatments for ß-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.
About | Leadership | DEI | About | About | About | Contact | Careers | About | About | About | About
Symbol: BLUE
Recent Price: $7.86
Industry: Biotechnology
CEO: Mr. Andrew Obenshain
Sector: Healthcare
Employees: 375
Address: 60 Binney Street, Cambridge, MA 02142
Phone: 339 499 9300
Leadership
- Sarah Alspach, Senior Vice President, External Affairs
- Rich Colvin, MD, PhD, Chief Medical Officer
- Kasra Kasraian, Senior Vice President, Technical Development and Operations
- Tom Klima, Chief Commercial & Operating Officer
- Andrew Obenshain, Chief Executive Officer
- Scott Shoemaker, Senior Vice President, Quality
- James Sterling, Chief Financial Officer
- Joe Vittiglio, Chief Business and Legal Officer
- Andrea Walton, Chief People Officer
- Leslie Wilder, Vice President, Head of Regulatory Science
- Mark Vachon, Chairman; Formerly of GE
- John O. Agwunobi, M.D., Formerly of Herbalife Nutrition
- Mike Cloonan, President and Chief Executive Officer, Sionna Therapeutics
- Charlotte Jones-Burton, M.D., Formerly of Chinook Therapeutics
- Lis Leiderman, M.D., CHIEF FINANCIAL OFFICER & CORPORATE DEVELOPMENT OFFICER AT DEWPOINT THERAPEUTICS
- Nick Leschly, Former Chief Kairos Officer, 2seventy Bio
- Richard Paulson, President and Chief Executive Officer at Karyopharm Therapeutics Inc.
- Najoh Tita-Reid, Chief Brand and Experience Officer, Mars Petcare
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Gritstone bio, Inc.
GRANITE
Gritstone bio, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies for cancer and infectious diseases, with lead products including GRANITE, SLATE, and CORAL.
Symbol: GRTS
Recent Price: $0.03
Industry: Biotechnology
CEO: Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.
Sector: Healthcare
Employees: 231
Address: 5959 Horton Street, EmeryVille, CA 94608
Phone: 510 871 6100
Last updated: 2024-12-31
Inhibikase Therapeutics, Inc.
Ik T-148009
Inhibikase Therapeutics, Inc. is a clinical stage pharmaceutical company focused on developing therapeutics for Parkinson's Disease and related disorders. Their product pipeline includes treatments for neurological and cancer-related conditions.
About | Leadership | Directors | About | About | About | Contact | Careers | About | About | About | About
Symbol: IKT
Recent Price: $3.24
Industry: Biotechnology
CEO: Dr. Milton H. Werner Ph.D.
Sector: Healthcare
Employees: 8
Address: 3350 Riverwood Parkway SE, Atlanta, GA 30339
Phone: 678 392 3419
Leadership
- Milton H. Werner, Ph.D., President and CEO
- C. Warren Olanow MD, FRCPC, FRCP (Hon.), Medical Consultant and CEO of Clintrex Research Corporation
- Garth Lees-Rolfe, CPA, Chief Financial Officer
- Dan Williams, Controller
- Terence Kelly, Ph.D., Medicinal Chemistry Consultant
- Surendra Singh, Ph.D., Chemistry and Manufacturing Controls
- Merrill M. Kraines, Partner, McDermott, Will & Emery, Outside General Counsel
- Roberto Bellini, Managing Partner at BSQUARED Capital
- Dennis Berman, Serial Entrepreneur
- David Canner, Ph.D., Partner at Soleus Capital
- Roy Freeman, M.D., Professor of Neurology at the Harvard Medical School, Director of the Center for Autonomic and Peripheral Nerve Disorders, Beth Israel Deaconess Medical Center
- Arvind Kush, Chief Financial Officer and Chief Business Officer of Candid Therapeutics
- Amit Munshi, Chief Executive Officer of Orna Therapeutics
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
Regulus Therapeutics Inc.
RG-012 and RGLS8429
Regulus Therapeutics Inc., based in San Diego, focuses on discovering and developing drugs targeting micro RNAs for treating various diseases.
Symbol: RGLS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Joseph P. Hagan M.B.A.
Sector: Healthcare
Employees: 30
Address: 4224 Campus Point Court, San Diego, CA 92121
Phone: 858 202 6300
Last updated: 2024-12-31
Soligenix, Inc.
SGX301 (Hy Bryte), SGX942, SGX203, SGX302
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases, operating in the Specialized Bio Therapeutics and Public Health Solutions segments.
About | Directors | About | About | About | About | About | About | Contact | About | About | About | About | About | Careers | Careers | About | About | About | About | About | About | About
Symbol: SNGX
Recent Price: $2.91
Industry: Biotechnology
CEO: Dr. Christopher J. Schaber Ph.D.
Sector: Healthcare
Employees: 13
Address: 29 Emmons Drive, Princeton, NJ 08540
Phone: 609 538 8200
Leadership
- Christopher J. Schaber, PhD, Chairman, President and Chief Executive Officer
- Gregg A. Lapointe, CPA, MBA, Board Director
- Diane L. Parks, MBA, Board Director
- Robert J. Rubin, MD, Board Director
- Jerome Zeldis, MD, PhD, Board Director
Last updated: 2024-12-31
Sonnet BioTherapeutics Holdings, Inc.
SON-1010, SON-080
Sonnet Bio Therapeutics Holdings, Inc. is a clinical stage oncology-focused biotechnology company developing biologic medicines using its human albumin binding technology. The company is based in Princeton, New Jersey, and has lead candidates such as SON-1010 for non-small cell lung cancer, and SON-080 for neuropathies.
Symbol: SONN
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Pankaj Mohan Ph.D.
Sector: Healthcare
Employees: 12
Address: 100 Overlook Center, Princeton, NJ 08540
Phone: 609-375-2227
Leadership
- Pankaj Mohan, Ph.D., Founder, CEO & Chairman
- Jay Cross, Chief Financial Officer
- John K. Cini, Ph.D., Chief Scientific Officer & Co-Founder
- Susan Dexter, Chief Technical Officer
- Richard Kenney, M.D., Chief Medical Officer
- Albert Dyrness, Board Member
- Nailesh Bhatt, Chief Executive Officer & Board Member
- Raghu Rao, Board Member
- Donald Griffith, Financial Controller
- Lori McNeill, Board Member
Last updated: 2024-12-31
Shattuck Labs, Inc.
SL-172154
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States, with its lead product candidate being SL-172154.
About | About | News | About | Contact | Culture | Leadership | Leadership
Symbol: STTK
Recent Price: $1.17
Industry: Biotechnology
CEO: Dr. Taylor H. Schreiber M.D., Ph.D.
Sector: Healthcare
Employees: 75
Address: 500 West 5th Street, Austin, TX 78703
Phone: 512 900 4690
Last updated: 2024-12-31
SpringWorks Therapeutics, Inc.
nirogacestat
SpringWorks Therapeutics acquires, develops, and commercializes medicines for underserved patient populations with rare diseases and cancer, focusing on products like nirogacestat for desmoid tumors and mirdametinib for neurofibromatosis.
Contact | Contact | Contact | Careers | Careers | Benefits | Careers | News | Events | ESG | About | About | About | About | Contact | About | About | Contact | About | About | About | About | About | About | About | About | Contact | About
Symbol: SWTX
Recent Price: $36.34
Industry: Biotechnology
CEO: Mr. Saqib Islam J.D.
Sector: Healthcare
Employees: 305
Address: 100 Washington Boulevard, Stamford, CT 06902
Phone: 203 883 9490
Last updated: 2024-12-31
Abeona Therapeutics Inc.
EB-101
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.
Symbol: ABEO
Recent Price: $5.61
Industry: Biotechnology
CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.
Sector: Healthcare
Employees: 84
Address: 1330 Avenue of the Americas, New York, NY 10019
Phone: 646 813 4701
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31